An Audit of Staphylococcus aureus Bacteraemia Treatment in a UK District General Hospital
Objective: Recent guidelines from Healthcare Improvement Scotland recommend that uncomplicated Staphylococcus aureus bacteraemia (SAB) be treated with effective antibiotics for at least 14 days. This audit aimed to see whether Medway Hospital, UK, was following these guidelines, and whether a simple intervention could improve compliance and therefore treatment. Method: All patients with SAB between April 2013 and September 2014 were identified and their clinical notes, laboratory findings and drug charts were reviewed. Starting in January 2014 all SAB were reported on the online pathology results system with the following advice; ‘Staphylococcus aureus bacteraemia warrants a minimum of 14 days treatment. Treatment may be longer in cases of deep seated infection.’ Outcome measures included 14 days antimicrobial treatment readmission rate with SAB, 3 month mortality post treatment and whether echocardiography was performed. Results: The demographics of all patients (35 pre and 39 post intervention) were comparable between groups (average age 63 vs 56, 54.3% vs 69.2% male) although the sources of bacteraemia differed slightly. More patients had indwelling lines in 2013 and there were a higher proportion of IV drug users in 2014; all other risk factors were similar between groups. More patients received appropriate antibiotics post intervention (74% vs 49%). Three month mortality with community acquired SAB increased but mortality with hospital acquired SAB decreased post intervention. Echocardiography uptake improved, and readmission rates with SAB decreased. Conclusion: The introduction of guidance with blood culture results has demonstrated better compliance with a 14 day minimum treatment length for SAB. Although sample size limits obtaining a statistically significant difference in readmission and mortality rates, this intervention still has the potential to improve treatment of SAB in aiding clinicians to follow guidelines. J Microbiol Infect Dis 2017; 7(4):188-193
Keywords:
HIV HCV, Genotype, Co-infection, Viral load,
___
- 1) Thwaites GE, Edgeworth JD, Gkrania-Klotsas E, et al. UK Clinical Infection Research Group. Clinical Management of Staphylococcus aureus Bacteraemias. Lancet Infect Dis 2011; 11: 208-22. 2) Van Hal SJ, Jenson S, Vaska V, et al. Predictors of Mortality in Staphlococcus aureus Bacteraemia. Clin Microbiol Rev 2012; 25: 362-386. 3) Wyllie D, Crooke D, Peto T. Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study. BMJ 2006; 333: 281. 4) Health Protection England: Health Protection Report. Voluntary surveillance of Staphylococcus aureus bacteraemia in England, Wales and Northern Ireland: 2007-2014 [online] (2015). Available at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/455607/hpr2915_saureus.pdf [Accessed 30.04.2016]. 5) Holland TL, Arnold C, Fowler VG Jr. Clinical Management of Staphylococcus Bacteremia: A Review. JAMA 2014; 312: 1330-1341. 6) Bai AD, Showler A, Burry L, et al. Impact of Infectious Disease Consultation on Quality of Care, Mortality, and Length of Stay in Staphylococcus aureus Bacteremia: Results From a Large Multicenter Cohort Study. Clin Infect Dis 2015; 60: 1451-1461. 7) Lahey T, Shah R, Gittzus J, Schwartzman J, Kirkland K. Infectious diseases consultation lowers mortality from Staphylococcus aureus bacteremia. Medicine (Baltimore); 88: 263-267. 8) Fowler VG Jr, Sanders LL, Sexton DJ, et al. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis 1998; 27: 478. 9) Healthcare Improvement Scotland. Guidance on management of proven or suspected Staphylococcus aureus bacteraemia in adults (2015). [online] Available at: https://www.scottishmedicines.org.uk/files/sapg1/SAB_algorithm.pdf [Accessed 04.05.2016]. 10) Gould FK, Brindle R, Chadwick PR, et al. MRSA Working Party of the British Society for Antimicrobial Chemotherapy. Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdomp. J Antimicrob Chemother 2009; 63: 849-861. 11) Liu C, Bayer A, Cosgrove SE, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children. Clin Infect Dis 2011; 52: 18-55. 12) Jensen AG, Wachmann CH, Espersen F, Scheibel J, Skinhøj P, Frimodt-Møller N. Treatment and outcome of Staphylococcus aureus bacteraemia: a prospective study of 278 cases. Arch Intern Med 2002; 162: 25-32. 13) Chong YP, Moon SM, Bang KM, et al. Treatment duration for uncomplicated Staphylococcus aureus bacteraemia to prevent relapse: analysis of a prospective observational cohort study. Antimicrob Agent Chemother 2013; 57:1150-1156. 14) Thwaites GE; United Kingdom Clinical Infection Research Group (UKCIRG). The management of Staphylococcus aureus bacteremia in the United Kingdom and Vietnam: a multi-centre evaluation. PLoS One 2010; 13; 5 (12):e14170. 15) EUCAST disk diffusion method. The British Society for Antimicrobial Chemotherapy, (2016). available at: http://bsac.org.uk/eucastbsac-disc-diffusion-method/ [Accessed 02.01.2017]. 16) Ringberg H, Thoren A, Lilja B. Metastatic complications of Staphlococcus aureus septicaemia. To seek is to find. Infection 2000; 28(3): 132-36. 17) López-Cortés LE, Del Toro MD, Gálvez-Acebal J, et al. REIPI/SAB group. Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of Staphylococcus aureus bacteremia. Clin Infect Dis 2013; 57(9):1225-33. 18) Turnidge JD, Kotsanas D, Munckhof W, et al. Australia New Zealand Cooperative on Outcomes in Staphylococcal Sepsis. Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand. Med J Aust 2009 Oct 5; 191(7):368-373. 19) Tong SY, Bishop EJ, Lilliebridge RA, et al. 2009. Community-associated strains of methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus in indigenous northern Australia: epidemiology and outcomes. J Infect Dis 2009; 199: 1461–1470.
- ISSN: 2146-3158
- Başlangıç: 2011
- Yayıncı: Sağlık Araştırmaları Derneği
Sayıdaki Diğer Makaleler
Francesca DİCKHAUS, Mutasim Abu HASAN, Elizabeth TREMBLAY, Kenneth KLİNKER, Kenneth RAND, Stacy G. BEAL
Nadeem Sajjad Raja, Albena Nikolova, Theo Raudsepp, Simon G Weston- Smith, Annette Rumbold, Sunil Gupta
Swati Sharma, Deepshikha Bhowmik, Amitabha Bhattacharjee
N. Dhaneshwor Singh, Nishi Sharma, Lobzang Dawa, Shalini Malhotra
Elda QYRA, Edmond PUCA, Arjan HARXHİ, Majlinda KOTE, Pellumb PİPERO
Yu Jun Wong, Bee Xian Tan, Maciej Piotr Chlebicki, Brian John Schwender
Parul Punia, Anita Chakravarti, Anjar Ashraf
Shree DHOTRE, Basavraj NAGOBA, Milind DAVANE, Mahesh DHARNE, Namdev SURYAWANSHİ
Christine SCARSBROOK, Nadeem Sajjad RAJA, Michael HARDMAN, Kath HUGHES
Arturo González Raya, Eva Martín Salido, Miguel Cantero Sánchez, Gonzalo Callejón Martín, María L. Hortas Nieto